CellWell record HH-140077
Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health
Chi-Hsien Lee; Thi Phuong Nam Bui; Camille Petitfils; Ching Jian; Giselle C Wong; Anthony Puel; Tiphaine Le Roy; Samuel Bellais; Bouthaina Ben Abdallah; Mélanie Nehlich; Thomas Leicht; Manyi Jia; Lesley Hoyles; Massimo Federici; Jose Manuel Fernández-Real; Remy Burcelin; Marc-Emmanuel Dumas; Nathalie M Delzenne; Thomas Clavel; Sjef Boeren; Antonio Dario Troise; Andrea Scaloni; Giulio G Muccioli; Willem M De Vos; Matthias Van Hul; Patrice D Cani
2026
In plain language
Researchers identified a myo-inositol-to-butyrate fermentation pathway in gut bacterium Dysosmobacter welbionis, whose supplementation improved glycemia and reduced hepatic steatosis in high-fat-diet-fed mice.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-140077
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.